These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 17508274)

  • 1. Risk assessment and genetic counseling for hereditary breast and ovarian cancer: recommendations of the National Society of Genetic Counselors.
    Berliner JL; Fay AM;
    J Genet Couns; 2007 Jun; 16(3):241-60. PubMed ID: 17508274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic cancer risk assessment and counseling: recommendations of the national society of genetic counselors.
    Trepanier A; Ahrens M; McKinnon W; Peters J; Stopfer J; Grumet SC; Manley S; Culver JO; Acton R; Larsen-Haidle J; Correia LA; Bennett R; Pettersen B; Ferlita TD; Costalas JW; Hunt K; Donlon S; Skrzynia C; Farrell C; Callif-Daley F; Vockley CW;
    J Genet Couns; 2004 Apr; 13(2):83-114. PubMed ID: 15604628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Essential elements of genetic cancer risk assessment, counseling, and testing: updated recommendations of the National Society of Genetic Counselors.
    Riley BD; Culver JO; Skrzynia C; Senter LA; Peters JA; Costalas JW; Callif-Daley F; Grumet SC; Hunt KS; Nagy RS; McKinnon WC; Petrucelli NM; Bennett RL; Trepanier AM
    J Genet Couns; 2012 Apr; 21(2):151-61. PubMed ID: 22134580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk assessment and genetic counseling for hereditary breast and ovarian cancer syndromes-Practice resource of the National Society of Genetic Counselors.
    Berliner JL; Cummings SA; Boldt Burnett B; Ricker CN
    J Genet Couns; 2021 Apr; 30(2):342-360. PubMed ID: 33410258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brief assessment of parents' attitudes toward testing minor children for hereditary breast/ovarian cancer genes: development and validation of the Pediatric BRCA1/2 Testing Attitudes Scale (P-TAS).
    Peshkin BN; DeMarco TA; Garber JE; Valdimarsdottir HB; Patenaude AF; Schneider KA; Schwartz MD; Tercyak KP
    J Pediatr Psychol; 2009 Jul; 34(6):627-38. PubMed ID: 18385162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical characterization and risk profile of individuals seeking genetic counseling for hereditary breast cancer in Brazil.
    Palmero EI; Ashton-Prolla P; da Rocha JC; Vargas FR; Kalakun L; Blom MB; Azevedo SJ; Caleffi M; Giugliani R; Schüler-Faccini L
    J Genet Couns; 2007 Jun; 16(3):363-71. PubMed ID: 17318454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Actionability of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Risk Assessment.
    Desmond A; Kurian AW; Gabree M; Mills MA; Anderson MJ; Kobayashi Y; Horick N; Yang S; Shannon KM; Tung N; Ford JM; Lincoln SE; Ellisen LW
    JAMA Oncol; 2015 Oct; 1(7):943-51. PubMed ID: 26270727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [BRCA1- and BRCA2 mutations: Clinical management of patients with hereditary breast and ovarian cancer].
    Pristauz G; Geigl JB; Petru E
    Wien Med Wochenschr; 2010 Apr; 160(7-8):158-62. PubMed ID: 20473725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pre-counseling education for low literacy women at risk of Hereditary Breast and Ovarian Cancer (HBOC): patient experiences using the Cancer Risk Education Intervention Tool (CREdIT).
    Joseph G; Beattie MS; Lee R; Braithwaite D; Wilcox C; Metrikin M; Lamvik K; Luce J
    J Genet Couns; 2010 Oct; 19(5):447-62. PubMed ID: 20490636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of a Standardized Tool to Identify Women at Risk for Hereditary Breast and Ovarian.
    Hessock M; Brewer T; Hutson S; Anderson J
    Nurs Womens Health; 2021 Jun; 25(3):187-197. PubMed ID: 33933425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BRCA1/2 testing in hereditary breast and ovarian cancer families: effectiveness of problem-solving training as a counseling intervention.
    McInerney-Leo A; Biesecker BB; Hadley DW; Kase RG; Giambarresi TR; Johnson E; Lerman C; Struewing JP
    Am J Med Genet A; 2004 Oct; 130A(3):221-7. PubMed ID: 15378542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hereditary breast and ovarian cancer (HBOC): clinical features and counseling for BRCA1 and BRCA2, Lynch syndrome, Cowden syndrome, and Li-Fraumeni syndrome.
    Shulman LP
    Obstet Gynecol Clin North Am; 2010 Mar; 37(1):109-33, Table of Contents. PubMed ID: 20494261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hereditary breast-ovarian cancer: clinical findings and medical management.
    Marshall M; Solomon S
    Plast Surg Nurs; 2007; 27(3):124-7. PubMed ID: 17901820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic counselors' perspectives on population-based screening for BRCA-related hereditary breast and ovarian cancer and Lynch syndrome.
    De Simone LM; Arjunan A; Vogel Postula KJ; Maga T; Bucheit LA
    J Genet Couns; 2021 Feb; 30(1):158-169. PubMed ID: 32562467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NSGC practice guideline: risk assessment and genetic counseling for hereditary breast and ovarian cancer.
    Berliner JL; Fay AM; Cummings SA; Burnett B; Tillmanns T
    J Genet Couns; 2013 Apr; 22(2):155-63. PubMed ID: 23188549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disclosure of genetics research results after the death of the patient participant: a qualitative study of the impact on relatives.
    Ormondroyd E; Moynihan C; Watson M; Foster C; Davolls S; Ardern-Jones A; Eeles R
    J Genet Couns; 2007 Aug; 16(4):527-38. PubMed ID: 17492498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hereditary breast and ovarian cancer: referral source for genetic assessment and communication regarding assessment with nongenetic clinicians in the community setting.
    Morgan D; Sylvester H; Lucas FL; Miesfeldt S
    Genet Med; 2010 Jan; 12(1):25-31. PubMed ID: 20027114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A survey of genetic counselors about the needs of 18-25 year olds from families with hereditary breast and ovarian cancer syndrome.
    Werner-Lin A; Ratner R; Hoskins LM; Lieber C
    J Genet Couns; 2015 Feb; 24(1):78-87. PubMed ID: 25011978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identifying Mediators of Intervention Effects Within a Randomized Controlled Trial to Motivate Cancer Genetic Risk Assessment Among Breast and Ovarian Cancer Survivors.
    An J; Lu SE; McDougall J; Walters ST; Lin Y; Heidt E; Stroup A; Paddock L; Grumet S; Toppmeyer D; Kinney AY
    Ann Behav Med; 2023 Oct; 57(11):965-977. PubMed ID: 37658805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.